STEVEN J. MENTO

Profile

First Name

: STEVEN

Middle Name

: J.

Last Name

: MENTO

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
CONATUS PHARMACEUTICALS INC
GARY C. BURGESS, CHARLES J. CASHION, JENNIFER GIOTTONINI CAYER, STEPHEN CHANG, PH.D., DAVID H. CREAN, DAVID CREAN, PH.D., MOYA DANIELS, ROCHELLE FUHRMANN, WILLIAM GERBER, WILLIAM GERBER, M.D., DAVID F. HALE, JONATHAN JACKSON, DANIEL L. KISNER, DANIEL KISNER, M.D., PAUL KLINGENSTEIN, PAUL H. KLINGENSTEIN, SUSAN A. KNUDSON, LOUIS LACASSE, MARTIN LATTERICH, SHAHZAD MALIK, SHAHZAD MALIK, M.D., STEVEN MENTO, PH.D., STEVEN J. MENTO, PH.D., GAIL NAUGHTON, GAIL K. NAUGHTON, RICHARD W. PASCOE, MARC PERET, MARC PERRET, JOYCE REYES, BRIAN SATZ, BRIAN SATZ, ESQ., JAMES SCOPA, ALFRED P. SPADA, ALFRED P. SPADA, PH.D., HAROLD VAN WART, HAROLD VAN WART, M.D., SUSAN WINDHAM-BANNISTER, HAYDEN YIZHUO ZHANG
EXECUTIVE OFFICER, DIRECTOR
HISTOGEN INC.
GARY C. BURGESS, CHARLES J. CASHION, JENNIFER GIOTTONINI CAYER, STEPHEN CHANG, PH.D., DAVID H. CREAN, DAVID CREAN, PH.D., MOYA DANIELS, ROCHELLE FUHRMANN, WILLIAM GERBER, WILLIAM GERBER, M.D., DAVID F. HALE, JONATHAN JACKSON, DANIEL L. KISNER, DANIEL KISNER, M.D., PAUL KLINGENSTEIN, PAUL H. KLINGENSTEIN, SUSAN A. KNUDSON, LOUIS LACASSE, MARTIN LATTERICH, SHAHZAD MALIK, SHAHZAD MALIK, M.D., STEVEN MENTO, PH.D., STEVEN J. MENTO, PH.D., GAIL NAUGHTON, GAIL K. NAUGHTON, RICHARD W. PASCOE, MARC PERET, MARC PERRET, JOYCE REYES, BRIAN SATZ, BRIAN SATZ, ESQ., JAMES SCOPA, ALFRED P. SPADA, ALFRED P. SPADA, PH.D., HAROLD VAN WART, HAROLD VAN WART, M.D., SUSAN WINDHAM-BANNISTER, HAYDEN YIZHUO ZHANG
DIRECTOR
DERMATA THERAPEUTICS, INC.
MARIA BEDOYA TORO MUNERA, BRITTANY BRADRICK, MARY FISHER, DAVID HALE, CHRISTOPHER J. NARDO, GERALD PROEHL, GERALD T. PROEHL, ANDREW SANDLER, KATHLEEN SCOTT, KYRI K. VAN HOOSE, WENDELL WIERENGA
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-01-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-12-29 
2025-02-04
D/A
Link
OTHER TECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-01-21 
2024-09-27
D
Link
OTHER TECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2024-09-17 
2023-06-12
D
Link
OTHER TECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2023-05-26 
2022-07-26
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2022-07-14 
2011-02-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-09 
2010-10-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-03-05